<SEC-DOCUMENT>0001610717-25-000290-index.html : 20250718
<SEC-HEADER>0001610717-25-000290.hdr.sgml : 20250718
<ACCEPTANCE-DATETIME>20250718171430
ACCESSION NUMBER:		0001610717-25-000290
CONFORMED SUBMISSION TYPE:	4
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20250716
FILED AS OF DATE:		20250718
DATE AS OF CHANGE:		20250718

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			BLATT LAWRENCE
		CENTRAL INDEX KEY:			0001242110
		ORGANIZATION NAME:           	

	FILING VALUES:
		FORM TYPE:		4
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-39617
		FILM NUMBER:		251135175

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Aligos Therapeutics, Inc.
		CENTRAL INDEX KEY:			0001799448
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				000000000
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	BUSINESS ADDRESS:	
		STREET 1:		ONE CORPORATE DR., 2ND FLOOR
		CITY:			SOUTH SAN FRANCISCO
		STATE:			CA
		ZIP:			94080
		BUSINESS PHONE:		(800) 466-6059

	MAIL ADDRESS:	
		STREET 1:		ONE CORPORATE DR., 2ND FLOOR
		CITY:			SOUTH SAN FRANCISCO
		STATE:			CA
		ZIP:			94080
</SEC-HEADER>
<DOCUMENT>
<TYPE>4
<SEQUENCE>1
<FILENAME>form4.xml
<TEXT>
Document 1 - file: form4.html

Document 1 - RAW XML: form4.xml

</DOCUMENT>
</SEC-DOCUMENT>